{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:17:45Z","timestamp":1788963465715,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clgc.2026.102648","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:50:13Z","timestamp":1786492213000},"page":"102648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Gleason Grade at the Positive Surgical Margin on Biochemical Recurrence After Radical Prostatectomy in pT2N0 Prostate Cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-8492","authenticated-orcid":false,"given":"Mehdi","family":"Kardoust Parizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-762X","authenticated-orcid":false,"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Ofner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Oliveira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-0827","authenticated-orcid":false,"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-4060","authenticated-orcid":false,"given":"Piotr","family":"Chlosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Leapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clgc.2026.102648_bib0001","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102648_bib0002","article-title":"The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis","volume":"19","author":"Guo","year":"2024","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.clgc.2026.102648_bib0003","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/j.clgc.2015.12.013","article-title":"Prognostic value of focal positive surgical margins after radical prostatectomy","volume":"14","author":"Lee","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2026.102648_bib0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41391-023-00654-6","article-title":"Length of positive surgical margins after radical prostatectomy: does size matter?\u2014a systematic review and meta-analysis","volume":"26","author":"John","year":"2023","journal-title":"Prost Cancer Prostat Dis"},{"issue":"1","key":"10.1016\/j.clgc.2026.102648_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eururo.2012.08.002","article-title":"The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment\u2013naive pT2\u20134 N0 radical prostatectomy patients","volume":"64","author":"Mauermann","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102648_bib0006","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.ju.0000169475.00949.78","article-title":"Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens","volume":"174","author":"Swindle","year":"2005","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102648_bib0007","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/j.clgc.2020.02.011","article-title":"Prognostic value of gleason score at positive surgical margin in prostate cancer: a systematic review and meta-analysis","volume":"18","author":"Lysenko","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2026.102648_bib0008","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.eururo.2007.10.008","article-title":"Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy","volume":"53","author":"Yossepowitch","year":"2008","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102648_bib0009","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II\u20142024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102648_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.23736\/S2724-6051.25.06642-X","article-title":"Contemporary methods for surgical margin assessment in radical prostatectomy: a systematic review and meta-analysis of diagnostic test accuracy","volume":"78","author":"Gaya","year":"2026","journal-title":"Minerva Urol Nephrol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102648_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/iju.70395","article-title":"Total positive margin length as a novel prognostic indicator after radical prostatectomy","volume":"33","author":"Hibino","year":"2026","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2026.102648_bib0012","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"issue":"9858","key":"10.1016\/j.clgc.2026.102648_bib0013","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clgc.2026.102648_bib0014","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.clgc.2026.102648_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102648_bib0016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.03.006","article-title":"Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localised prostate cancer","volume":"4","author":"Martini","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2026.102648_bib0017","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pros.24341","article-title":"Impact of positive surgical margin length and gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer","volume":"82","author":"Preisser","year":"2022","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.clgc.2026.102648_bib0018","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102648_bib0019","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00345-026-06231-5","article-title":"Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up","volume":"44","author":"Pellegrino","year":"2026","journal-title":"World J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:59:38Z","timestamp":1788962378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1558767326001485"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102648","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Gleason Grade at the Positive Surgical Margin on Biochemical Recurrence After Radical Prostatectomy in pT2N0 Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102648"}}